SCHEMBL19383124

SCHEMBL19383124

N#Cc1ccc(-c2cccc(-c3cc(-c4ccccc4)nc(Cl)n3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 5/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ HPGD P15428 3/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ KDM4E B2RXH2 3/20 0.54
▸ MAPT P10636 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ GABRA1 P14867 2/20 0.51
▸ GABRG2 P18507 2/20 0.51
▸ GABRB3 P28472 2/20 0.51
▸ GABRA5 P31644 2/20 0.51
▸ GABRA3 P34903 2/20 0.51
▸ MYC P01106 1/20 0.51
▸ ALDH1A3 P47895 2/20 0.48
▸ ABCG2 Q9UNQ0 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ ABCB1 P08183 1/20 0.45
▸ ADORA2A P29274 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15308297 0.94 L3MBTL1 (0.67) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL15308225 0.92 L3MBTL1 (0.69) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL22912145 0.87 MEN1 (0.77) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL24776412 0.87 ABCG2 (0.53) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL30030272 0.87 ABCG2 (0.53) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL23383792 0.87 ABCG2 (0.58) KMT2AMEN1HPGDALDH1A1SMN1; SMN2
SCHEMBL15308290 0.86 L3MBTL1 (0.65) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL15458641 0.86 MEN1 (0.80) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL19383481 0.86 MEN1 (0.80) L3MBTL1KMT2AMEN1HPGDALDH1A1
SCHEMBL15458659 0.86 MEN1 (0.80) L3MBTL1KMT2AMEN1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-04-11 — — US disclosed
WO-2017157983-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2017-09-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES TEC, NUDT1, DPYD L3MBTL1 4788/4885KMT2A 3153/4885MEN1 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback